Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Ulecaciclib |
| Trade Name | |
| Synonyms | auceliciclib|AU3-14|AU314 |
| Drug Descriptions |
Ulecaciclib is a second-generation CDK4/6 inhibitor, which potentially inhibits Rb phosphorylation and induces cell cycle arrest in tumor cells and reduces tumor growth (PMID: 40651458). |
| DrugClasses | CDK4/6 Inhibitor 15 |
| CAS Registry Number | 2075750-05-7 |
| NCIT ID | C203109 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Temozolomide + Ulecaciclib | Temozolomide Ulecaciclib | 0 | 0 |
| Ulecaciclib | Ulecaciclib | 0 | 0 |